Coupling RNA polymerase II transcription with pre-mRNA processing

Current Opinion in Cell Biology

Volumn 11, Issue 3, 1999, Pages 347-351

  Bentley, David ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; MESSENGER RNA PRECURSOR; RIBONUCLEOPROTEIN; RNA POLYMERASE II;

CARBOXY TERMINAL SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; RNA PROCESSING; RNA SPLICING; RNA TRANSCRIPTION;

GALLUS GALLUS;

EID: 0033152538     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)80048-9     Document Type: Review

References (51)

1. Smale ST, Tjian R: Transcription of herpes simplex virus tk sequences under the control of wild-type and mutant human RNA polymerase I promoters. Mol Cell Biol 1985, 5:352-362.
2. Sisodia SS, Sollner WB, Cleveland DW: Specificity of RNA maturation pathways: RNAs transcribed by RNA polymerase III are not substrates for splicing or polyadenylation. Mol Cell Biol 1987, 7:3602-3612.
3. McCracken S, Rosonina E, Fong N, Sikes M, Beyer A, O'Hare K, Shuman S, Bentley D: Role of RNA polymerase II carboxy-terminal domain in coordinating transcription with RNA processing. Cold Spring Harbor Symp Quant Biol 1998, LXIII:301-310.
4. Green MR, Maniatis T, Melton DA: Human beta-globin premRNA synthesized in vitro is accurately spliced in Xenopus oocyte nuclei. Cell 1983, 32:681-694.
5. Coppola JA, Field AS, Luse DS: Promoter-proximal pausing by RNA polymerase II in vitro: Transcripts shorter than 20 nucleotides are not capped. Proc Natl Acad Sci USA 1983, 80:1251-1255.
6. Rasmussen EB, Lis JT: In-vivo transcriptional pausing and cap formation on 3 Drosophila heat-shock genes. Proc Natl Acad Sci USA 1993, 90:7923-7927.
7. Visa N, Izaurralde E, Ferreira J, Daneholt B, Mattaj IW: A nuclear capbinding complex binds balbiani ring pre-mRNA cotranscriptionally and accompanies the ribonucleoprotein particle during nuclear export J Cell Biol 1996, 133:5-14.
8. Takagi T, Moore C, Diehn F, Buratowski S: An RNA 5′-triphosphatase related to the protein tyrosine phosphatases. Cell 1997, 89:867-873.
9. Tsukamoto T, Shibagaki Y, Imajoh-Ohmi S, Murakoshi T, Suzuki M, Nakamura A, Gotoh H, Mizumoto K: Isolation and characterization of the yeast mRNA capping enzyme beta subunit gene encoding RNA 5′-triphosphatase, which is essential for cell viability. Biochem Biophys Res Commun 1997, 239:116-122.
10. Ho CK, Schwer B, Shuman S: Genetic, physical, and functional interactions between the triphosphatase and guanylyltransferase components of the yeast mRNA capping apparatus. Mol Cell Biol 1998, 18:5189-5198.
11. Dahmus ME: Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J Biol Chem 1996, 271:19009-19012.
12. O'Brien T, Hardin S, Greenleaf A, Lis JT: Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature 1994, 370:75-77.
13. McCracken S, Fong N, Rosonina E, Yankulov K, Brothers G, Siderovski D, Hessel A, Foster S, Amgen Est Program, Shuman S, Bentley D: 5′-capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev 1997, 11:3306-3318. This study shows that capping in vivo is an RNA polymerase II CTD dependent processing step and that two of the capping enzymes bind the phosphorylated CTD in vitro.
14. Cho EJ, Takagi T, Moore CR, Buratowski S: mRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 1997, 11:3319-3326. The authors report the important result that yeast guanylyltransferase associates with ternary complexes of DNA, RNA transcript and phosphorylated RNA pol II. They also demonstrate a genetic interaction between the pol II CTD and yeast guanylyltransferase.
15. Yue Z, Maldonado E, Pilluta R, Cho H, Reinberg D, Shatkin A: Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylyltransferase and selectively binds the elongating form of RNA pol II. Proc Natl Acad Sci USA 1997, 94:12898-12903. Demonstrates binding of mammalian capping enzyme to elongating (phosphorylated) RNA pol II but not the initiating (nonphosphorylated) form.
16. Ho CK, Sriskanda V, McCracken S, Bentley D, Schwer B, Shuman S: The guanylyltransferase domain of mammalian mRNA capping enzyme binds to the phosphorylated carboxyl-terminal domain of RNA polymerase II. J Biol Chem 1998, 273:9577-9585.
17. Cho EJ, Rodriguez CR, Takagi T, Buratowski S: Allosteric interactions between capping enzyme subunits and the RNA polymerase II carboxy-terminal domain. Genes Dev 1998, 12:3482-3487. Shows for the first time regulation of the activity of a processing factor, yeast guanylyltransferase, by its interaction with the RNA pol II CTD.
18. Ho C, Shuman S: Distinct effector roles for Ser2 and Ser5 phosphorylation of the RNA polymerase II CTD in the recruitment and allosteric activation of mammalian capping enzyme. Mol Cell 1999, 3:405-411. The authors show that a peptide with only four CTD heptad repeats not only binds mammalian guanylyltransferase but also activates it. Activation is dependent on a particular phosphorylated serine residue (Ser5) in the RNA pol II CTD repeat.
19. Zhu YR, Peery T, Peng TM, Ramanathan Y, Marshall N, Marshall T, Amendt B, Mathews MB, Price DH: Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev 1997, 11:2622-2632.
20. Lo HJ, Huang HK, Donahue TF: RNA polymerase i-promoted HIS4 expression yields uncapped, polyadenylated mRNA that is unstable and inefficiently translated in Saccharomyces cerevisiae. Mol Cell Biol 1998, 18:665-675.
21. McCracken S, Fong N, Yankulov K, Ballantyne S, Pan GH, Greenblatt J, Patterson SD, Wickens M, Bentley DL: The C-terminal domain of RNA polymerase II couples messenger RNA processing to transcription. Nature 1997, 385:357-361. This study shows that splicing, 3′-end processing and termination of pol II transcription are abrogated in transfected cells by deletion of the RNA pol II CTD. Interaction of the polyadenylation factors CstF and CPSF with RNA pol II is demonstrated.
22. McNeil JB, Agah H, Bentley D: Activated transcription independent of the RNA polymerase II holoenzyme in budding yeast. Genes Dev 1998, 12:2510-2521.
23. Hirose Y, Manley JL: RNA polymerase II is an essential mRNA polyadenylation factor. Nature 1998, 395:93-96. This important study shows for the first time that the RNA pol II CTD can stimulate the transcript cleavage reaction independent of transcription. It may therefore function as a bona fide processing factor.
24. Dantonel JC, Murthy KG, Manley JL, Tora L: Transcription factor TFIID recruits factor CPSF for formation of 3′ end of mRNA. Nature 1997, 389:399-402. The authors sequenced polypeptides of the basal transcription factor TFIID, and found, to everyone's surprise, that they include three subunits of the polyadenylation factor CPSF. They provide evidence for a handover of CPSF from TFIID to pol II when transcription starts.
25. Proudfoot NJ: How RNA polymerase II terminates transcription in higher eukaryotes. Trends Biochem Sci 1989, 14:105-110.
26. Birse CE, Minvielle-Sebastia L, Lee BA, Keller W, Proudfoot NJ: Coupling termination of transcription to messenger RNA maturation in yeast. Science 1998, 280:298-301. An elegant dissection of which components of the polyadenylation machinery are necessary for coupled termination. The authors demonstrate that the cleavage factor 1A is important but not the polyadenylation factor PF1.
27. Osheim Y, Proudfoot N, Beyer A: EM visualization of transcription by RNA polymerase II: Downstream termination requires a poly(A) signal but not transcript cleavage. Mol Cell 1999, 3:379-387. A graphic demonstration that RNA transcript cleavage is not a necessary pre-requisite for termination of transcription by RNA pol II.
28. Dye M, Proudfoot N: Terminal exon definition occurs cotranscriptionally and promotes termination of RNA polymerase II. Mol Cell 1999, 3:371-378. This study uses a novel nuclear run-on method to show that transcripts elongated in isolated nuclei can extend far beyond the poly(A) site without being cleaved. It also reports that splicing of the terminal intron is coupled to termination.
29. Bauren G, Belikov S, Wieslander L: Transcriptional termination in the balbiani ring 1 gene is closely coupled to 3′-end formation and excision of the 3′-terminal intron. Genes Dev 1998, 12:2759-2769. A tour de force, probably the most thorough analysis ever of events at the 3′-end of an RNA pol II transcription unit. The authors demonstrate that closely coupled cleavage, polyadenylation, termination, and splicing of the last intron occur when the polymerase reaches a point 600 bases downstream of the poly(A) site.
30. Niwa M, Rose SD, Berget SM: In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes Dev 1990, 4:1552-1559.
31. Nesic D, Cheng J, Maquat LE: Sequences within the last intron function in RNA 3′-end formation in cultured cells. Mol Cell Biol 1993, 13:3359-3369.
32. Cmarko D, Verschure PJ, Martin TE, Dahmus ME, Krause S, Fu XD, van Driel R, Fakan S: Ultrastructural analysis of transcription and splicing in the cell nucleus after bromo-UTP microinjection. Mol Biol Cell 1999, 10:211-223.
33. Schul W, van Driel R, de Jong L: A subset of poly(A) polymerase is concentrated at sites of RNA synthesis and is associated with domains enriched in splicing factors and poly(A) RNA. Exp Cell Res 1998, 238:1-12. A thorough quantitative study of the co-localisation of sites of pol II transcription with RNA processing factors in the nucleoplasm.
34. Schul W, Groenhout B, KOberna K, Takagaki Y, Jenny A, Manders E, Raska I, van Driel R, de Jong L: The RNA 3′ cleavage factors CstF 64 kDa and CPSF 100 kDa are concentrated in nuclear domains closely associated with coiled bodies and newly synthesized RNA. EMBO J 1996, 15:2883-2892.
35. Beyer AL, Osheim YN: Splice site selection, rate of splicing, and alternative splicing on nascent transcripts. Genes Dev 1988, 2:754-765.
36. Bauren G, Wieslander L: Splicing of balbiani ring 1 gene pre-mRNA occurs simultaneously with transcription. Cell 1994, 76:183-192.
37. Yuryev A, Patturajan M, Litingtung Y, Joshi R, Gentile C, Gebara M, Corden J: The CTD of RNA polymerase II interacts with a novel set of SR-like proteins. Proc Natl Acad Sci USA 1996, 93:6975-6980.
38. Du L, Warren SL: Functional interaction between the carboxy terminal domain of RNA polymerase II and pre-messenger RNA splicing. J Cell Biol 1997, 136:5-18. Some of the first evidence of a functional role of the RNA pol II CTD in splicing in vivo. Demonstrates that CTD overexpression inhibits splicing.
39. Kim E, Du L, Bregman DB, Warren SL: Splicing factors associate with hyperphosphorylated RNA polymerase II in the absence of pre-messenger RNA. J Cell Biol 1997, 136:19-28. This study provides some of the best evidence for biochemical interactions between splicing factors and phosphorylated RNA pol II.
40. Mortillaro MJ, Blencowe BJ, Wei XY, Nakayasu H, Du L, Warren SL, Sharp PA, Berezney R: A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc Natl Acad Sci USA 1996, 93:8253-8257.
41. Vincent M, Lauriault P, Dubois MF, Lavoie S, Bensaude O, Chabot B: The nuclear matrix protein p255 is a highly phosphorylated form of RNA polymerase II largest subunit which associates with spliceosomes. Nucleic Acids Res 1996, 24:4649-4652.
42. Patturajan M, Wei X, Berezney R, Corden JL: A nuclear matrix protein interacts with the phosphorylated C-terminal domain of RNA polymerase II. Mol Cell Biol 1998, 18:2406-2415. This study characterises a member of a family of nuclear matrix associated proteins, SCAFs, with SR-rich domains and a conserved domain that binds strongly to phosphorylated RNA pol II CTD.
43. Corden JL, Patturajan M: A CTD function linking transcription to splicing. Trends Biochem Sci 1997, 22:413-416.
44. Bourquin JP, Stagljar I, Meier P, Moosmann P, Silke J, Baechi T, Georgiev O, Schaffner W: A serine/arginine-rich nuclear matrix cyclophilin interacts with the C-terminal domain of RNA polymerase II. Nucleic Acids Res 1997, 25:2055-2061. Describes a new RNA pol II CTD binding protein with an SR-rich domain and a peptidyl-prolyl isomerase domain.
45. Cramer P, Pesce C, Baralle F, Kornblihtt A: Functional association between promoter structure and transcripts alternative splicing. Proc Natl Acad Sci USA 1997, 94:11456-11460. This paper documents a role of the promoter in the control of splicing. Mutation of two discrete promoter elements altered the frequency of inclusion of an alternative fibronectin exon which depends on an exonic splicing enhancer.
46. Lavigueur A, La Branche H, Kornblihtt AR, Chabot B: A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev 1993, 7:2405-2417.
47. Tacke R, Manley JL: The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J 1995, 14:3540-3551.
48. Ge H, Si Y, Roeder RG: Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J 1998, 17:6723-6729.
49. Ge H, Si Y, Wolffe AP: A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2. Mol Cell 1998, 2:751-759. This study reports the remarkable finding that a co-activator of RNA pol II transcription in vitro binds to and functionally synergises with the splicing factor ASF/SF2.
50. Iacampo S, Cochrane A: Human immunodeficiency virus type 1 Rev function requires continued synthesis of its target mRNA. J Virol 1996, 70:8332-8339.
51. Visa N, Alzhanova EA, Sun X, Kiseleva E, BJoerkroth B, Wurtz T, Daneholt B: A pre-mRNA-binding protein accompanies the RNA from the gene through the nuclear pores and into polysomes. Cell 1996, 84:253-264.